ORIGINAL ARTICLE
Year : 2013  |  Volume : 6  |  Issue : 3  |  Page : 212-216

Topical application of tranexamic acid as a surgical hemostat in primary coronary artery bypass graft surgery: a comparative study


1 Department of Anesthesiology, Ain Shams University, Cairo, Egypt
2 Department of Cardiothoracic Surgery, Ain Shams University, Cairo, Egypt
3 6th of October University, Cairo, Egypt

Correspondence Address:
Rasha S. Bondok
MD, Department of Anesthesiology, Ain Shams University, 33 Hassan Maamoun, Nasr City, 11391 Cairo
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Background Antifibrinolytics are widely used in cardiac surgery to reduce bleeding and allogenic blood transfusion. The aim of this study was to compare the efficacy of local application of tranexamic acid (TXA) with its intravenous route in patients during coronary artery bypass graft (CABG) surgery. Methods A total of 106 patients undergoing primary CABG were assigned to one of two groups. Group ITXA received intravenous TXA: initially, a bolus of 1 g, followed by continuous infusion of 400 mg/h during the surgical procedure. Group LTXA received 1 g of TXA diluted in 100 ml of isotonic saline delivered into the pericardium and mediastinal cavities before closure of sternotomy. The primary end-point was 24-h postoperative blood loss. Results The total amount of blood loss postoperatively was similar in both groups (379 ± 20.73 vs. 384± 23.57ml in the LTXA and the ITXA group, respectively, P= 0.235). The number of packed red blood cell unit transfusion per patient was comparable in both groups (1.0± 0.86 vs. 1.16± 0.89U in LTXA and ITXA, respectively, P= 0.425). No incidences of postoperative myocardial infarction were encountered in either groups. Troponin I levels were similar in both groups. Reoperation for nonspecific bleeding was three of 50 patients (6%) in the ITXA group and two of 52 patients (4%) in the LTXA group. Conclusion Local application of TXA is considered effectively similar in reducing postoperative bleeding and transfusion requirements as its intravenous route in patients undergoing on-pump CABG, with the advantage of providing lower doses of the drug.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed857    
    Printed25    
    Emailed0    
    PDF Downloaded220    
    Comments [Add]    

Recommend this journal